One BRCA2 mutation carrier (Patient 10) had an ER + primary breast tumor and two recurrences lacking TP53 mutations; instead, the tumor appeared to be driven by the oncogenic AKT1 E17K mutation42,43. This evidence concerns the gene AKT1 and breast neoplasm.